Total planned funding: $27,331,053
Clear active filters
Other USG Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Zambia | $5,150,434 |
| Nigeria | $4,433,283 |
| Mozambique | $3,970,980 |
| Uganda | $3,131,239 |
| South Africa | $1,764,935 |
| Tanzania | $1,589,274 |
| Namibia | $1,019,246 |
| Ethiopia | $866,736 |
| Eswatini | $692,655 |
| Ukraine | $635,000 |
| Lesotho | $627,000 |
| Kenya | $598,406 |
| Malawi | $557,454 |
| Ghana | $400,000 |
| Botswana | $345,000 |
| Cameroon | $342,179 |
| Caribbean Region | $300,000 |
| Central America Region | $239,572 |
| Rwanda | $238,118 |
| Asia Regional Program | $176,448 |
| Dominican Republic | $100,000 |
| Democratic Republic of the Congo | $58,094 |
| Guyana | $50,000 |
| Papua New Guinea | $45,000 |
| Vietnam | $0 |
| Côte d'Ivoire | $0 |
| Zimbabwe | $0 |
| Central Asia Region | $0 |
Organizational Types
| Other USG Agency | $27,331,053 |
Program Areas
| Governance and Systems | $6,784,999 |
| Care | $4,588,494 |
| Prevention | $4,271,805 |
| Treatment | $2,764,551 |
| Management and Operations | $904,413 |
| Testing | $151,264 |
Budget Codes
| HLAB: Laboratory Infrastructure | $3,182,591 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,057,193 |
| HKID: Care: Orphans and Vulnerable Children | $3,044,785 |
| HTXS: Treatment: Adult Treatment | $2,437,228 |
| HVSI: Strategic Information | $1,933,947 |
| OHSS: Health Systems Strengthening | $1,668,461 |
| HBHC: Care: Adult Care and Support | $1,243,931 |
| HVMS: Management and Operations | $904,413 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $501,240 |
| HMBL: Biomedical Prevention: Blood Safety | $454,687 |
| PDTX: Treatment: Pediatric Treatment | $327,323 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $195,168 |
| HVTB: Care: TB/HIV | $174,715 |
| HVCT: Testing: HIV Testing and Counseling | $151,264 |
| PDCS: Care: Pediatric Care and Support | $125,063 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $63,517 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| HTXD: Treatment: ARV Drugs | $0 |